Antimicrobial activity of carbon-based nanoparticles

Advanced Pharmaceutical Bulletin

Volumn 5, Issue 1, 2015, Pages 19-23

  Dizaj, Solmaz Maleki ^a   Mennati, Afsaneh ^b   Jafari, Samira ^a   Khezri, Khadejeh ^b   Adibkia, Khosro ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Faculty of Science Physical Chemistry Group Uremia Payam Noor University   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial activity; Antimicrobial mechanism; Carbon nanotubes; Fullerene; Graphene oxide; Metal carbon nanocomposites

Indexed keywords

FULLERENE DERIVATIVE; GRAPHENE OXIDE; SINGLE WALLED NANOTUBE;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRUCTURES; BACTERICIDAL ACTIVITY; CELL DAMAGE; CELL MEMBRANE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; METABOLISM; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; TOXICITY;

EID: 84924369469     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2015.003     Document Type: Article

References (49)

1. Allahverdiyev AM, Abamor ES, Bagirova M, Rafailovich M. Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol 2011;6(8):933-40.
2. Adibkia K, Omidi Y, Siahi MR, Javadzadeh AR, Barzegar-Jalali M, Barar J, et al. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J Ocul Pharmacol Ther 2007;23(5):421-32.
3. Tiwari PM, Vig K, Dennis VA, Singh SR. Functionalized gold nanoparticles and their biomedical applications. Nanomater 2011;1(1):31-63.
4. Zinjarde SS. Bio-inspired nanomaterials and their applications as antimicrobial agents. Chronic Young Sci 2012;3(1):74-81.
5. Bahrami K, Nazari P, Nabavi M, Golkar M, Almasirad A, Shahverdi AR. Hydroxyl capped silver-gold alloy nanoparticles: characterization and their combination effect with different antibiotics against Staphylococcus aureus. Nanomed J 2014;1(3):155-61.
6. Ravishankar Rai V, Jamuna Bai A. Nanoparticles and their potential application as antimicrobials. A Méndez-Vilas A, editor. Mysore: Formatex; 2011.
7. Marambio-Jones C, Hoek EM. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 2010;12(5):1531-51.
8. Adibkia K, Barzegar-Jalali M, Nokhodchi A, Siahi Shadbad M, Omidi Y, Javadzadeh Y, et al. A review on the methods of preparation of pharmaceutical nanoparticles. Pharm Sci 2010;15(4):303-14.
9. Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization. Colloids Surf B Biointerfaces 2011;83(1):155-9.
10. Mohammadi G, Nokhodchi A, Barzegar-Jalali M, Lotfipour F, Adibkia K, Ehyaei N, et al. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces 2011;88(1):39-44.
11. Kannan RR, Jerley AJA, Ranjani M, Prakash VSG. Antimicrobial silver nanoparticle induces organ deformities in the developing Zebrafish (Danio rerio) embryos. J Biomed Sci Engine 2011;4;248-54.
12. Azam A, Ahmed AS, Oves M, Khan MS, Habib SS, Memic A. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int J Nanomedicine 2012;7:6003-9.
13. Besinis A, De Peralta T, Handy RD. The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine on Streptococcus mutans using a suite of bioassays. Nanotoxicology 2014;8(1):1-16.
14. Emami-Karvani Z, Chehrazi P. Antibacterial activity of ZnO nanoparticle on grampositive and gram-negative bacteria. Afr J Microbiol Res 2011;5(12):1368-73.
15. Usman MS, El Zowalaty ME, Shameli K, Zainuddin N, Salama M, Ibrahim NA. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine 2013;8:4467-79.
16. Chen Q, Xue Y, Sun J. Kupfer cell-mediated hepatic injury induced by silica nanoparticles in vitro and in vivo. Int J Nanomedicine 2013;8:1129-40.
17. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microb 2007;73(6):1712-20.
18. Zarei M, Jamnejad A, Khajehali E. Antibacterial Effect of Silver Nanoparticles Against Four Foodborne Pathogens. Jundishapur J Microb 2014;7(1):E8720.
19. Cataldo F, Da Ros T. Medicinal chemistry and pharmacological potential of fullerenes and carbon nanotubes. Trieste: Springer; 2008.
20. Wang JT, Chen C, Wang E, Kawazoe Y. A new carbon allotrope with six-fold helical chains in all-sp2 bonding networks. Sci Rep 2014;4:4339.
21. Sokolov VI, Stankevich IV. The fullerenes-new allotropic forms of carbon: molecular and electronic structure, and chemical properties. Russ Chem Rev 1993;62(5):419.
22. Kang S, Herzberg M, Rodrigues DF, Elimelech M. Antibacterial effects of carbon nanotubes: size does matter! Langmuir 2008;24(13):6409-13.
23. Buzea C, Pacheco, Ii, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007;2(4):MR17-71.
24. Hajipour MJ, Fromm KM, Ashkarran AA, Jimenez De Aberasturi D, De Larramendi IR, Rojo T, et al. Antibacterial properties of nanoparticles. Trends Biotechnol 2012;30(10):499-511.
25. Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomedicine 2012;7:5901-14.
26. Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol Appl Pharmacol 2012;261(2):121-33.
27. Vecitis CD, Zodrow KR, Kang S, Elimelech M. Electronic-structure-dependent bacterial cytotoxicity of single-walled carbon nanotubes. ACS nano 2010;4(9):5471-9.
28. Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int 2013;2013:942916.
29. Pacurar M, Qian Y, Fu W, Schwegler-Berry D, Ding M, Castranova V, Guo NL. Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in humanmicrovascular endothelial cells. J Toxicol Environ Health A 2012;75(3):129-47.
30. Kang S, Pinault M, Pfefferle LD, Elimelech M. Single-walled carbon nanotubes exhibit strong antimicrobial activity. Langmuir 2007;23(17):8670-3.
31. Yang C, Mamouni J, Tang Y, Yang L. Antimicrobial activity of single-walled carbon nanotubes: length effect. Langmuir 2010;26(20):16013-9.
32. Murray AR, Kisin ER, Tkach AV, Yanamala N, Mercer R, Young SH, et al. Factoring-in agglomeration of carbon nanotubes and nanofibers for better prediction of their toxicity versus asbestos. Part Fibre Toxicol 2012;9:10.
33. Bellucci S. Nanoparticles and Nanodevices in Biological Applications. Germany: Springer-Verlag, Berlin-Heidelberg; 2009.
34. Dinadayalane TC, Leszczynska D, Leszczynski J. Towards Efficient Designing of Safe Nanomaterials. Leszczynski J, Puzyn T, Kroto H, editors. Cambridge, UK: Royal society of chemistry; 2012.
35. Yang K, Wan J, Zhang S, Zhang Y, Lee ST, Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS nano 2011;5(1):516-22.
36. Han J. Carbon Nanotubes: Science and Application. Meyyappan M, editor. Boca Raton: CRC Press LLC; 2005.
37. Arias LR, Yang L. Inactivation of bacterial pathogens by carbon nanotubes in suspensions. Langmuir 2009;25(5):3003-12.
38. Dong L, Henderson A, Field C. Antimicrobial activity of single-walled carbon nanotubes suspended in different surfactants. J Nanotechnol 2012;2012:1-7.
39. Tegos GP, Demidova TN, Arcila-Lopez D, Lee H, Wharton T, Gali H, et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 2005;12(10):1127-35.
40. Deryabin DG, Davydova OK, Yankina ZZ, Vasilchenko AS, Miroshnikov SA, Kornev AB, et al. The Activity of [60] Fullerene Derivatives Bearing Amine and Carboxylic Solubilizing Groups against Escherichia coli: A Comparative Study. J Nanomater 2014;2014:1-9.
41. Yang X, Ebrahimi A, Li J, Cui Q. Fullerene-biomolecule conjugates and their biomedicinal applications. Int J Nanomedicine 2014;9:77-92.
42. Nakamura S, Mashino T. Biological activities of water-soluble fullerene derivatives. J Phys Conf Ser 2009;159:012003
43. Sharma SK, Chiang LY, Hamblin MR. Photodynamic therapy with fullerenes in vivo: reality or a dream? Nanomedicine (Lond) 2011;6(10):1813-25.
44. Lu Z, Dai T, Huang L, Kurup DB, Tegos GP, Jahnke A, et al. Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) 2010;5(10):1525-33.
45. Mizuno K, Zhiyentayev T, Huang L, Khalil S, Nasim F, Tegos GP, et al. Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships. J Nanomed Nanotechnol 2011;2(2):1-9.
46. Azimi S, Behin J, Abiri R, Rajabi L, Derakhshan AA, Karimnezhad H. Synthesis, Characterization and Antibacterial Activity of Chlorophyllin Functionalized Graphene Oxide Nanostructures. Sci Adv Mater 2014;6(4):771-81.
47. Akhavan O, Ghaderi E. Toxicity of Graphene and Graphene Oxide Nanowalls Against Bacteria. Acs nano 2010;4:5731.
48. Yun H, Kim JD, Choi HC, Lee CW. Antibacterial Activity of CNT-Ag and GO-Ag Nanocomposites Against Gram-negative and Gram-positive Bacteria. Bull Korean Chem Soc 2013;34(11):3261.
49. Leid J, Ditto A, Knapp A, Shah P, Wright B, Blust R, et al. In vitro antimicrobial studies of silver carbine complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J Antimicrob Chemother 2012;67:138-48.